Using a closure analysis method to reduce CGT contamination risks
Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contam...
How to make in-use stability and compatibility studies a success
In-use stability and compatibility studies are often used in biotherapeutic development to assess biologic drugs with diluents and/or administration components. The studies are done in conditions that are relevant for th...
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Where can you read about industry trends, progress against shared challenges, and best practice solutions...
Formulation team sweeps away barriers to sharing
Biopharmaceutical formulations often present as complex mixtures that can be sensitive to heat, light, and many other fa...
Speed to Clinic initiative launches: learning from the COVID-19 pandemic
LONG READSpeed to Clinic initiative launches: learning from the COVID-19 pandemic Spurred on by lessons learned from...
How to create a toolbox to assess your high-risk HCPs
Host cell proteins (HCPs) are process-related impurities derived from host cells that may co-purify with a biopharmaceut...
BioPhorum launch new sustainability phorum
BioPhorum members have given us a clear message; to be an industry that supports sustainability is extremely important t...
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...
Overcoming unique challenges to support rapid development of diverse products
LONG READOvercoming unique challenges to support rapid development of diverse productsThe Cell and Gene Therapy (CGT)...
How to overcome the hurdles of using small-scale models
Small-scale models (SSMs) are critical to biopharmaceutical process development, technology transfer, process characteri...
The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements
Driving the harmonization of regulatory requirements – one country at a time Regulations play a significant role...
The Qualification of Small-Scale Models Workstream addresses the gap in industry alignment and regulatory guidance
LONG READThe Qualification of Small-Scale Models Workstream addresses the gap in industry alignment and regulatory...
Successful outsourcing offers solutions to increased demand across the biopharmaceutical industry
As demand increases across the biopharmaceutical industry, the need for streamlined approaches increases in turn. This...
Outsourcing development services offers solutions for increased demand
Many companies have increasingly sought to outsource chemistry, manufacturing, and controls (CMC) development services. ...
How to make in-use stability and compatibility studies a success
In-use stability and compatibility studies are often used in biotherapeutic development to assess biologic drugs with di...
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Where can you read about industry trends, progress against shared challenges, and best practice solutions...
Formulation team sweeps away barriers to sharing
Biopharmaceutical formulations often present as complex mixtures that can be sensitive to heat, light, and many other fa...
Speed to Clinic initiative launches: learning from the COVID-19 pandemic
LONG READSpeed to Clinic initiative launches: learning from the COVID-19 pandemic Spurred on by lessons learned from...
How to create a toolbox to assess your high-risk HCPs
Host cell proteins (HCPs) are process-related impurities derived from host cells that may co-purify with a biopharmaceut...
BioPhorum launch new sustainability phorum
BioPhorum members have given us a clear message; to be an industry that supports sustainability is extremely important t...
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...
Overcoming unique challenges to support rapid development of diverse products
LONG READOvercoming unique challenges to support rapid development of diverse productsThe Cell and Gene Therapy (CGT)...
How to overcome the hurdles of using small-scale models
Small-scale models (SSMs) are critical to biopharmaceutical process development, technology transfer, process characteri...
The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements
Driving the harmonization of regulatory requirements – one country at a time Regulations play a significant role...
The Qualification of Small-Scale Models Workstream addresses the gap in industry alignment and regulatory guidance
LONG READThe Qualification of Small-Scale Models Workstream addresses the gap in industry alignment and regulatory...
Successful outsourcing offers solutions to increased demand across the biopharmaceutical industry
As demand increases across the biopharmaceutical industry, the need for streamlined approaches increases in turn. This...